Fertility preservation during cancer treatment: Clinical guidelines

Cancer Management and Research

Volumn 6, Issue 1, 2014, Pages 105-117

  Rodriguez Wallberg, Kenny A ^a,b   Oktay, Kutluk ^c,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Innovation Institute for Fertility Preservation Rye and New York   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Cancer; Cancer survival; Cryopreservation; Fertility preservation; Fertility sparing surgery; Ovarian tissue transplantation; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER RISK; CANCER SURGERY; CHEMORADIOTHERAPY; CRYOPRESERVATION; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; GONADAL DISEASE; GONADAL TISSUE; GYNECOLOGIC CANCER; HUMAN; MALE FERTILITY; MALE INFERTILITY; NONHUMAN; OOCYTE; PATIENT SAFETY; PRACTICE GUIDELINE; PREPUBERTY; REPRODUCTIVE HEALTH; REVIEW; RISK REDUCTION; SPERM PRESERVATION; SURGICAL TECHNIQUE; TESTIS CANCER; TISSUE PRESERVATION; TISSUE TRANSPLANTATION; TISSUES; TREATMENT INDICATION;

EID: 84895756985     PISSN: None     EISSN: 11791322     Source Type: Book Series    
DOI: 10.2147/CMAR.S32380     Document Type: Review

References (137)

1. Swedish Official Statistics. Cancer Incidence in Sweden 2011. Updated 2012. Available from: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18919/2012-12-19.pdf. Accessed October 30, 2013.
2. International Agency for Research on Cancer. EUCAN. Cancer Factsheets. 2013. Available from: http://eco.iarc.fr/EUCAN/. Accessed October 30, 2013.
3. Health Improvement Scotland. Long term follow up of survivors of childhood cancer. A national clinical guideline. 2013. Available from: http://www.sign.ac.uk/pdf/sign132.pdf. Accessed October 30, 2013.
4. United Kingdom Childhood Cancer Study. Subfertility risk consensus document, 2005. Available from: http://www.ukccs.org/. Accessed October 30, 2013.
5. Burstein HJ, Winer EP. Primary care for survivors of breast cancer. N Engl J Med. 2000;343(15):1086-1094.
6. Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol. 1999;17(8):2365-2370.
7. Grigg A. The impact of conventional and high-dose therapy for lymphoma on fertility. Clin Lymphoma. 2004;5(2):84-88.
8. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;34:12-17.
9. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18(1):117-121.
10. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738-744.
11. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol. 2005;6(4):209-218.
12. Fleischer RT, Vollenhoven BJ, Weston GC. The effects of chemotherapy and radiotherapy on fertility in premenopausal women. Obstet Gynecol Surv. 2011;66(4):248-254.
13. Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys. 2009;73(5):1304-1312.
14. Wallberg KA, Keros V, Hovatta O. Clinical aspects of fertility preservation in female patients. Pediatr Blood Cancer. 2009;53(2):254-260.
15. Rodriguez-Wallberg KA. Principles of cancer treatment: impact on reproduction. Adv Exp Med Biol. 2012;732:1-8.
16. Pacey AA. Fertility issues in survivors from adolescent cancers. Cancer Treat Rev. 2007;33(7):646-655.
17. Schover LR. Psychosocial aspects of infertility and decisions about reproduction in young cancer survivors: a review. Med Pediatr Oncol. 1999;33(1):53-59.
18. Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer. 1999;86(4):697-709.
19. Duffy C, Allen S. Medical and psychosocial aspects of fertility after cancer. Cancer J. 2009;15(1):27-33.
20. Rosen A, Rodriguez-Wallberg KA, Rosenzweig L. Psychosocial distress in young cancer survivors. Semin Oncol Nurs. 2009;25(4):268-277.
21. Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst. 2012;104(5):386-405.
22. Quinn GP, Vadaparampil ST, Bell-Ellison BA, Gwede CK, Albrecht TL. Patient-physician communication barriers regarding fertility preservation among newly diagnosed cancer patients. Soc Sci Med. 2008;66(3):784-789.
23. Armuand GM, Rodriguez-Wallberg KA, Wettergren L, etal. Sex differences in fertility-related information received by young adult cancer survivors. J Clin Oncol. 2012;30(17):2147-2153.
24. Letourneau JM, Smith JF, Ebbel EE, etal. Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer. Cancer. 2012;118(18):4579-4588.
25. National Cancer Institute. SEER Cancer Statistics Review 1975-2007. Updated 2011. Available from: http://seer.cancer.gov/archive/csr/1975_2007/. Accessed October 30, 2013.
26. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics. 2014. CA: A Cancer Journal for Clinicians. 2014;64:9-29.
27. Dargent D, Mathevet P. [Radical laparoscopic vaginal hysterectomy]. J Gynecol Obstet Biol Reprod (Paris). 1992;21(6):709-710.
28. Morice P, Uzan C, Gouy S, etal. [Effects of radiotherapy (external and/or internal) and chemotherapy on female fertility]. Bull Acad Natl Med. 2010;194(3):481-492. French.
29. Liou WS, Yap OW, Chan JK, Westphal LM. Innovations in fertility preservation for patients with gynecologic cancers. Fertil Steril. 2005;84(6):1561-1573.
30. Abu-Rustum NR, Sonoda Y. Fertility-sparing surgery in early-stage cervical cancer: indications and applications. J Natl Compr Canc Netw. 2010;8(12):1435-1438.
31. Plante M, Gregoire J, Renaud MC, Roy M. The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol. 2011;121(2):290-297.
32. Li J, Li Z, Wang H, etal. Radical abdominal trachelectomy for cervical malignancies: surgical, oncological and fertility outcomes in 62 patients. Gynecol Oncol. 2011;121(3):565-570.
33. Testa R, Ramirez PT, Ferreyra H, etal. Abdominal radical a safe and feasible option for fertility preservation in developing countries. J Low Genit Tract Dis. 2013;17(4):378-384.
34. Speiser D, Köhler C, Schneider A, Mangler M. Radical vaginal trachelectomy: a fertility-preserving procedure in early cervical cancer in young women. Dtsch Arztebl Int. 2013;110(17):289-295.
35. Pareja R, Rendón GJ, Sanz-Lomana CM, Monzón O, Ramirez PT. Surgical, oncological, and obstetrical outcomes after abdominal radical trachelectomy-a systematic literature review. Gynecol Oncol. 2013;131(1):77-82.
36. Vercellino GF, Piek JM, Schneider A, etal. Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer. Gynecol Oncol. 2012;126(3):325-329.
37. Wethington SL, Sonoda Y, Park KJ, etal. Expanding the indications for radical trachelectomy: a report on 29 patients with stage IB1 tumors measuring 2 to 4 centimeters. Int J Gynecol Cancer. 2013;23(6): 1092-1098.
38. Kesic V, Rodolakis A, Denschlag D, etal. Fertility preserving management in gynecologic cancer patients: the need for centralization. Int J Gynecol Cancer. 2010;20(9):1613-1619.
39. Ungár L, Smith JR, Pálfalvi L, Del Priore G. Abdominal radical trachelectomy during pregnancy to preserve pregnancy and fertility. Obstet Gynecol. 2006;108(3 Pt 2):811-814.
40. Sioutas A, Schedvins K, Larson B, Gemzell-Danielsson K. Three cases of vaginal radical trachelectomy during pregnancy. Gynecol Oncol. 2011;121(2):420-421.
41. Sabanegh ES Jr, Ragheb AM. Male fertility after cancer. Urology. 2009;73(2):225-231.
42. Heidenreich A, Weissbach L, Höltl W, etal. Organ sparing surgery for malignant germ cell tumor of the testis. J Urol. 2001;166(6): 2161-2165.
43. Baniel J, Sella A. Sperm extraction at orchiectomy for testis cancer. Fertil Steril. 2001;75(2):260-262.
44. Choi BB, Goldstein M, Moomjy M, Palermo G, Rosenwaks Z, Schlegel PN. Births using sperm retrieved via immediate microdissection of a solitary testis with cancer. Fertil Steril. 2005;84(5):1508.
45. Schrader M, Müller M, Sofikitis N, Straub B, Krause H, Miller K. "Onco-tese": testicular sperm extraction in azoospermic cancer patients before chemotherapy-new guidelines? Urology. 2003;61(2):421-425.
46. Gosden RG, Wade JC, Fraser HM, Sandow J, Faddy MJ. Impact of congenital or experimental hypogonadotrophism on the radiation sensitivity of the mouse ovary. Hum Reprod. 1997;12(11):2483-2488.
47. Speiser B, Rubin P, Casarett G. Aspermia following lower truncal irradiation in Hodgkin's disease. Cancer. 1973;32(3):692-698.
48. Rodriguez-Wallberg KA, Oktay K. Fertility preservation medicine: options for young adults and children with cancer. J Pediatr Hematol Oncol. 2010;32(5):390-396.
49. Sklar C. Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Paediatr Suppl. 1995;411:57-61.
50. Thibaud E, Rodriguez-Macias K, Trivin C, Espérou H, Michon J, Brauner R. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant. 1998;21(3):287-290.
51. Green DM, Sklar CA, Boice JD Jr, etal. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2374-2381.
52. Shalet SM, Tsatsoulis A, Whitehead E, Read G. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol. 1989;120(1):161-165.
53. Lee SJ, Schover LR, Partridge AH, etal. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917-2931.
54. Hudson MM. Reproductive outcomes for survivors of childhood cancer. Obstet Gynecol. 2010;116(5):1171-1183.
55. Barton SE, Najita JS, Ginsburg ES, etal. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2013;14(9):873-881.
56. Oktem O, Oktay K. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res. 2007;67(21):10159-10162.
57. Kalich-Philosoph L, Roness H, Carmely A, etal. Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5(185):185ra62.
58. Rodriguez-Wallberg KA, Alonso de Mena S, Malm E, Larsson A, Kuiper R, Hassan M. Pre-pubertal status does not protect against follicle depletion induced by cyclophosphamide in mice. A randomized study. Hum Reprod. 2013;28 Suppl 1:P321.
59. Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod. 2001;16(4):632-637.
60. Simon B, Lee SJ, Partridge AH, Runowicz CD. Preserving fertility after cancer. CA Cancer J Clin. 2005;55(4):211-228.
61. Dodds L, Marrett LD, Tomkins DJ, Green B, Sherman G. Case-control study of congenital anomalies in children of cancer patients. BMJ. 1993;307(6897):164-168.
62. Langagergaard V, Gislum M, Skriver MV, etal. Birth outcome in women with breast cancer. Br J Cancer. 2006;94(1):142-146.
63. Dalberg K, Eriksson J, Holmberg L. Birth outcome in women with previously treated breast cancer-a population-based cohort study from Sweden. PLoS Med. 2006;3(9):e336.
64. Soleimani R, Heytens E, Darzynkiewicz Z, Oktay K. Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise. Aging (Albany NY). 2011;3(8): 782-793.
65. Loren AW, Mangu PB, Beck LN, etal; American Societyof Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2013;31(19):2500-2510.
66. National Institute for Health Care and Excellence. Fertility: assessment and treatment for people with fertility problems. Available from: http://publications.nice.org.uk/fertility-cg156. Accessed October 30, 2013.
67. Cancer Council Australia [homepage on the Internet]. Sydney: Cancer Council Australia. Available from: http://www.cancer.org.au. Accessed November 19, 2013.
68. ReproductiveFacts. org [homepage on the Internet]. Birmingham, AL: The American Society for Reproductive Medicine. Available from: http://www.asrm.org. Accessed November 19, 2013.
69. International Society for Fertility Presentation [homepage on the Internet]. Kansas: International Society for Fertility Presentation. Available from: http://www.isfp-fertility.org. Accessed November 19, 2013.
70. Brison D, Cutting R, Clarke H, Wood M. ACE consensus meeting report: oocyte and embryo cryopreservation Sheffield 17.05.11. Hum Fertil (Camb). 2012;15(2):69-74.
71. Pacey AA, Eiser C. Banking sperm is only the first of many decisions for men: what health care professionals and men need to know. Hum Fertil (Camb). 2011;14(4):208-217.
72. Guérin JF. [Testicular tissue cryoconservation for prepubertal boy: indications and feasibility]. Gynecol Obstet Fertil. 2005;33(10):804-808. French.
73. Bahadur G, Ling KL, Hart R, etal. Semen quality and cryopreservation in adolescent cancer patients. Hum Reprod. 2002;17(12):3157-3161.
74. Menon S, Rives N, Mousset-Siméon N, etal. Fertility preservation in adolescent males: experience over 22 years at Rouen University Hospital. Hum Reprod. 2009;24(1):37-44.
75. Meseguer M, Molina N, García-Velasco JA, Remohí J, Pellicer A, Garrido N. Sperm cryopreservation in oncological patients: a 14-year follow-up study. Fertil Steril. 2006;85(3):640-645.
76. Morey AF, Deshon GE Jr, Rozanski TA, Dresner ML. Technique of biopty gun testis needle biopsy. Urology. 1993;42(3):325-326.
77. Baerwald AR, Adams GP, Pierson RA. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril. 2003;80(1):116-122.
78. von Wolff M, Thaler CJ, Frambach T, etal. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril. 2009;92(4):1360-1365.
79. Sönmezer M, Türkçüoǧlu I, Coşkun U, Oktay K. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril. 2011;95(6):2125. e9-e11.
80. Marrs RP, Greene J, Stone BA. Potential factors affecting embryo survival and clinical outcome with cryopreserved pronuclear human embryos. Am J Obstet Gynecol. 2004;190(6):1766-1771.
81. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril. 2006;86(1):70-80.
82. Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2008;90(Suppl 5):S241-S246.
83. Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99(1):37-43.
84. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18(6):769-776.
85. Cil AP, Bang H, Oktay K. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. Fertil Steril. 2013;100(2):492-499. e3.
86. Rodriguez-Wallberg KA, Oktay K. Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer. Oncologist. 2012;17(11):1409-1417.
87. Titus S, Li F, Stobezki R, etal. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci Transl Med. 2013;5(172):172ra21.
88. Rodriguez-Wallberg KA, Oktay K. Fertility preservation in women with breast cancer. Clin Obstet Gynecol. 2010;53(4):753-762.
89. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23(19):4347-4353.
90. Tulandi T, Martin J, Al-Fadhli R, etal. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril. 2006;85(6):1761-1765.
91. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26(16):2630-2635.
92. Oktay K, Lee S, Kim JY, etal. Long-term outcomes and safety of letrozole-FSH protocol in women with breast cancer undergoing fertility preservation: a prospective-controlled study. Fertil Steril. 2010;94(4 Suppl 1):S11.
93. Chian RC, Gilbert L, Huang JY, etal. Live birth after vitrification of in vitro matured human oocytes. Fertil Steril. 2009;91(2):372-376.
94. Oktay K, Buyuk E, Rodriguez-Wallberg KA, Sahin G. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online. 2010;20(5):634-638.
95. Donnez J, Dolmans MM, Demylle D, etal. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364(9443):1405-1410.
96. Donnez J, Silber S, Andersen CY, etal. Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births. Ann Med. 2011;43(6):437-450.
97. Oktay K, Türkçüoǧlu I, Rodriguez-Wallberg KA. Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: what is the explanation? Fertil Steril. 2011;95(2):804. e7-e10.
98. Rodriguez-Wallberg KA, Borgstrom B, Sheikhi M. Lundqvist ML, Hovatta O. Cryopreservation of oocytes and gonadal tissue in a large fertility preservation programme at a teaching hospital. Hum Reprod. 2010;25 Suppl 1:i104.
99. von Wolff M, Donnez J, Hovatta O, etal. Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy-a technique in its infancy but already successful in fertility preservation. Eur J Cancer. 2009;45(9):1547-1553.
100. Smitz J, Dolmans MM, Donnez J, etal. Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update. 2010;16(4):395-414.
101. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med. 2000;342(25): 1919.
102. Andersen CY, Rosendahl M, Byskov AG, etal. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod. 2008;23(10):2266-2272.
103. Oktay K, Buyuk E, Veeck L, etal. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;363(9412):837-840.
104. Sonmezer M, Oktay K. Orthotopic and heterotopic ovarian tissue transplantation. Best Pract Res Clin Obstet Gynaecol. 2010;24(1): 113-126.
105. Rodriguez-Wallberg KA, Oktay K. Recent advances in oocyte and ovarian tissue cryopreservation and transplantation. Best Pract Res Clin Obstet Gynaecol. 2012;26(3):391-405.
106. Soleimani R, Heytens E, Oktay K. Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants. PLoS One. 2011;29;6(4):e19475.
107. Dolmans MM, Luyckx V, Donnez J, Andersen CY, Greve T. Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013;99(6):1514-1522.
108. Greve T, Clasen-Linde E, Andersen MT, etal. Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood. 2012;120(22):4311-4316.
109. Rosendahl M, Greve T, Andersen CY. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Assist Reprod Genet. 2013;30(1):11-24.
110. Meirow D, Hardan I, Dor J, etal. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod. 2008;23(5):1007-1013.
111. Greve T, Wielenga VT, Grauslund M, etal. Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination. Eur J Cancer. 2013;49(8):1932-1938.
112. Sauvat F, Capito C, Sarnacki S, etal. Immature cryopreserved ovary restores puberty and fertility in mice without alteration of epigenetic marks. PLoS One. 2008;3(4):e1972.
113. Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP, Hovatta O. Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod. 2006;21(9):2223-2227.
114. Telfer EE, McLaughlin M, Ding C, Thong KJ. A two-step serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin. Hum Reprod. 2008;23(5):1151-1158.
115. Telfer EE, Zelinski MB. Ovarian follicle culture: advances and challenges for human and nonhuman primates. Fertil Steril. 2013;99(6): 1523-1533.
116. Baert Y, Van Saen D, Haentjens P, In't Veld P, Tournaye H, Goossens E. What is the best cryopreservation protocol for human testicular tissue banking? Hum Reprod. 2013;28(7):1816-1826.
117. Keros V, Hultenby K, Borgström B, Fridström M, Jahnukainen K, Hovatta O. Methods of cryopreservation of testicular tissue with viable spermatogonia in pre-pubertal boys undergoing gonadotoxic cancer treatment. Hum Reprod. 2007;22(5):1384-1395.
118. Dovey SL, Valli H, Hermann BP, etal. Eliminating malignant contamination from therapeutic human spermatogonial stem cells. 2013;123(4):1833-1843.
119. Goossens E, Van Saen D, Tournaye H. Spermatogonial stem cell preservation and transplantation: from research to clinic. Hum Reprod. 2013;28(4):897-907.
120. Oktay K, Briggs D, Gosden RG. Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab. 1997;82(11):3748-3751.
121. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000;21(2):200-201.
122. Letourneau JM, Ebbel E, Katz P, etal. The prevalence of self-reported reproductive impairment in young female cancer survivors throuhgout California. Fertil Steril. 2010;94(4):510.
123. Turner NH, Partridge A, Sanna G, Di Leo A, Biganzoli L. Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain. Ann Oncol. 2013;24(9):2224-2235.
124. Meistrich ML. Male gonadal toxicity. Pediatr Blood Cancer. 2009;53(2):261-266.
125. Meistrich ML, Wilson G, Ye WS, Kurdoglu B, Parchuri N, Terry NH. Protection from procarbazine-induced testicular damage by hormonal pretreatment does not involve arrest of spermatogonial proliferation. Cancer Res. 1994;54(4):1027-1034.
126. Meistrich ML, Shetty G. Hormonal suppression for fertility preservation in males and females. Reproduction. 2008;136(6):691-701.
127. Li F, Turan V, Lierman S, Cuvelier C, De Sutter P, Oktay K. Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death. Hum Reprod. 2014;29(1):107-113.
128. Skinner R, Wallace WH, Levitt GA; UK Children's Cancer Study Group Late Effects Group. Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol. 2006;7(6):489-498.
129. Byrne J, Fears TR, Steinhorn SC, etal. Marriage and divorce after childhood and adolescent cancer. JAMA. 1989;262(19):2693-2699.
130. Partridge AH, Gelber S, Peppercorn J, etal. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22(20):4174-4183.
131. Forman EJ, Anders CK, Behera MA. Pilot survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. J Reprod Med. 2009;54(4):203-207.
132. Merrick H, Wright E, Pacey AA, Eiser C. Finding out about sperm banking: what information is available online for men diagnosed with cancer? Hum Fertil (Camb). 2012;15(3):121-128.
133. Sonoda Y, Chi DS, Carter J, Barakat RR, Abu-Rustum NR. Initial experience with Dargent's operation: the radical vaginal trachelectomy. Gynecol Oncol. 2008;108(1):214-219.
134. Morris RT, Gershenson DM, Silva EG, Follen M, Morris M, Wharton JT. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol. 2000;95(4):541-547.
135. Morice P, Camatte S, Wicart-Poque F, etal. Results of conservative management of epithelial malignant and borderline ovarian tumours. Hum Reprod Update. 2003;9(2):185-192.
136. Tangir J, Zelterman D, Ma W, Schwartz PE. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol. 2003;101(2):251-257.
137. Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol. 2005;17(3):299-308.